On Monday, Cellectar Biosciences Inc (NASDAQ: CLRB) was 5.75% up from the session before settling in for the closing price of $0.37. A 52-week range for CLRB has been $0.22 – $4.17.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
When this article was written, the company’s average yearly earnings per share was at 47.54%. With a float of $45.31 million, this company’s outstanding shares have now reached $46.08 million.
The firm has a total of 11 workers. Let’s measure their productivity. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Cellectar Biosciences Inc (CLRB) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Cellectar Biosciences Inc stocks. The insider ownership of Cellectar Biosciences Inc is 1.67%, while institutional ownership is 11.18%. The most recent insider transaction that took place on Jan 10 ’25, was worth 8,400. In this transaction Chief Operating Officer of this company bought 30,000 shares at a rate of $0.28, taking the stock ownership to the 83,141 shares.
Cellectar Biosciences Inc (CLRB) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.15 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 47.54% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 16.51% during the next five years compared to 40.27% growth over the previous five years of trading.
Cellectar Biosciences Inc (NASDAQ: CLRB) Trading Performance Indicators
You can see what Cellectar Biosciences Inc (CLRB) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 2.58.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.51, a number that is poised to hit -0.16 in the next quarter and is forecasted to reach -0.70 in one year’s time.
Technical Analysis of Cellectar Biosciences Inc (CLRB)
Analysing the last 5-days average volume posted by the [Cellectar Biosciences Inc, CLRB], we can find that recorded value of 1.37 million was lower than the volume posted last year of 1.81 million. As of the previous 9 days, the stock’s Stochastic %D was 80.52%. Additionally, its Average True Range was 0.03.
During the past 100 days, Cellectar Biosciences Inc’s (CLRB) raw stochastic average was set at 8.41%, which indicates a significant decrease from 88.48% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 67.21% in the past 14 days, which was lower than the 240.56% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.2936, while its 200-day Moving Average is $1.5304. Now, the first resistance to watch is $0.4052. This is followed by the second major resistance level at $0.4201. The third major resistance level sits at $0.4438. If the price goes on to break the first support level at $0.3666, it is likely to go to the next support level at $0.3429. Should the price break the second support level, the third support level stands at $0.3280.
Cellectar Biosciences Inc (NASDAQ: CLRB) Key Stats
There are 46,080K outstanding shares of the company, which has a market capitalization of 17.98 million. As of now, sales total 0 K while income totals -44,580 K. Its latest quarter income was 0 K while its last quarter net income were -7,420 K.
